Show
Sort by
-
Offering HPV self-sampling kits : an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
-
- Journal Article
- A1
- open access
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
-
Cellular senescence in neuroblastoma
-
- Journal Article
- A1
- open access
A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma
-
- Journal Article
- A1
- open access
Antibiotic use and risk of colorectal cancer : a systematic review and dose-response meta-analysis
-
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
-
Poor outcome in hypoxic endometrial carcinoma is related to vascular density
-
- Journal Article
- A1
- open access
The anaphase-promoting complex/cyclosome : a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma
-
End-of-life decision-making across cancer types : results from a nationwide retrospective survey among treating physicians
-
- Journal Article
- A1
- open access
Practice-changing radiation therapy trials for the treatment of cancer : where are we 150 years after the birth of Marie Curie?
-
L1CAM expression in endometrial carcinomas : an ENITEC collaboration study
-
Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation
-
- Journal Article
- A1
- open access
Predicting microbiologically defined infection in febrile neutropenic episodes in children : global individual participant data multivariable meta-analysis
-
International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data
-
Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer
-
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
-
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
-
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
-
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
-
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
-
- Journal Article
- A1
- open access
Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
-
- Journal Article
- A1
- open access
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
-
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
-
KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis
-
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
-
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
-
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
-
Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?
-
Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
-
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
-
- Journal Article
- A1
- open access
Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study
-
Health state utilities for metastatic breast cancer
-
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
-
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
-
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
-
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens
-
Invasion and MMP expression profile in desmoid tumours
-
BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
-
HSAbodies: A new class of engineered antibody-based molecules for targeting cancer
-
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression
-
Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition
-
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
-
Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.
-
Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
-
Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures.
-
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen.
-
Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: Cooperation between src and HGF/Met in invasion.
-
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
-
Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha.
-
Paclitaxel for malignant pleural mesothelioma: A phase II study of the EORTC Lung Cancer Cooperative Group.
-
ACTIVATION OF THE E-CADHERIN/CATENIN COMPLEX IN HUMAN MCF-7 BREAST-CANCER CELLS BY ALL-TRANS-RETINOIC ACID
-
IN-VIVO AND IN-VITRO INVASION IN RELATION TO PHENOTYPIC CHARACTERISTICS OF HUMAN COLORECTAL-CARCINOMA CELLS.
-
Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.
-
C-ERBB-2 POSITIVE BREAST-TUMORS BEHAVE MORE AGGRESSIVELY IN THE 1ST YEARS AFTER DIAGNOSIS.
-
COMPARISON OF THE ANTIEMETIC EFFICACY OF DIFFERENT DOSES OF ONDANSETRON, GIVEN AS EITHER A CONTINUOUS INFUSION OR A SINGLE INTRAVENOUS DOSE, IN ACUTE CISPLATIN-INDUCED EMESIS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP-STUDY.
-
RETINOIC ACID MODULATES BOTH INVASION AND PLASMA-MEMBRANE RUFFLING OF MCF-7 HUMAN MAMMARY-CARCINOMA CELLS-INVITRO.